Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Brain Research|April 17, 2009
Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitisJessica Carmen, Jeffrey D Rothstein, Douglas A Kerr
International Review of Psychiatry (Abingdon, England)|January 13, 2006
The immune system and neuropsychiatric diseasesDouglas Kerr, Chitra Krishnan, Michele L Pucak, et al.
Glia|May 13, 2006
Altered immune response to CNS viral infection in mice with a conditional knock-down of macrophage-lineage cellsJessica Carmen, Genevieve Gowing, Jean-Pierre Julien, et al.
Regenerative Medicine|December 16, 2011
Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process developmentJessica Carmen, Scott R Burger, Michael McCaman, et al.
Progress in Neurobiology|April 24, 2007
Revisiting the astrocyte-oligodendrocyte relationship in the adult CNSJessica Carmen, Tim Magnus, Riccardo Cassiani-Ingoni, et al.
Experimental Neurology|April 16, 2008
Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degenerationAngelo C Lepore, Christine Dejea, Jessica Carmen, et al.
Glia|November 21, 2007
Adult glial precursor proliferation in mutant SOD1G93A miceTim Magnus, Jessica Carmen, Jessica Deleon, et al.
Cytotherapy|December 25, 2012
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industryChristopher A Bravery, Jessica Carmen, Timothy Fong, et al.
Cytotherapy|September 23, 2017
A roadmap for cost-of-goods planning to guide economic production of cell therapy productsYonatan Y Lipsitz, William D Milligan, Ian Fitzpatrick, et al.
Annals of Neurology|June 28, 2006
Recovery from paralysis in adult rats using embryonic stem cellsDeepa M Deshpande, Yun-Sook Kim, Tara Martinez, et al.
Pageof 1